| Literature DB >> 17387481 |
F Birnbaum1, A Reis, T Reinhard.
Abstract
Topical steroids are routinely used in the postoperative treatment following penetrating keratoplasty. Due to the known side effects such as steroid-response glaucoma, cataract, and surface disorders, a broader armamentarium of topical immunomodulating drugs with comparable efficacy, better tolerance and less side effects is desirable. Cyclosporine A and FK506 eye drops are a promising alternative. A new approach involves subconjunctival drug delivering implants and locally applied antiangiogenic substances, which still have to be tested in clinical studies.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17387481 DOI: 10.1007/s00347-007-1516-y
Source DB: PubMed Journal: Ophthalmologe ISSN: 0941-293X Impact factor: 1.059